Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients

Saul Eugene Rivkin; James Moon; Desiree S Iriarte; Erik Bailey; Heather L Sloan; Gary E Goodman; Amy E BonDurant; Dan Velijovich; Tanya Wahl; Peter Jiang; Chirag A Shah; Charles Drescher; Mehmet F Fer; Henry G Kaplan; Erin D Ellis

doi:10.1136/ijgc-2018-000035

Article info

other Versions

View the most recent version of this article
You are currently viewing an earlier version of this article (March 31, 2021).

Original Article

Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients

Authors

Saul Eugene Rivkin Swedish Cancert Institute, Seattle, Washington, USA Marsha Rivkin Center for Ovarian Cancer Research, Seattle, Washington, USA PubMed articles Google scholar articles
James Moon Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articles Google scholar articles
Desiree S Iriarte Swedish Cancert Institute, Seattle, Washington, USA PubMed articles Google scholar articles
Erik Bailey Swedish Cancert Institute, Seattle, Washington, USA PubMed articles Google scholar articles
Heather L Sloan Swedish Cancert Institute, Seattle, Washington, USA PubMed articles Google scholar articles
Gary E Goodman Swedish Cancert Institute, Seattle, Washington, USA PubMed articles Google scholar articles
Amy E BonDurant Pacific Gynecology Specialists, Seattle, Washington, USA PubMed articles Google scholar articles
Dan Velijovich Pacific Gynecology Specialists, Seattle, Washington, USA PubMed articles Google scholar articles
Tanya Wahl Swedish Cancert Institute, Seattle, Washington, USA PubMed articles Google scholar articles
Peter Jiang Providence Regional Cancer Partnership Everett Clinic, Everett, Washington, USA PubMed articles Google scholar articles
Chirag A Shah Pacific Gynecology Specialists, Seattle, Washington, USA PubMed articles Google scholar articles
Charles Drescher Pacific Gynecology Specialists, Seattle, Washington, USA PubMed articles Google scholar articles
Mehmet F Fer Swedish Cancert Institute, Seattle, Washington, USA PubMed articles Google scholar articles
Henry G Kaplan Swedish Cancert Institute, Seattle, Washington, USA PubMed articles Google scholar articles
Erin D Ellis Swedish Cancert Institute, Seattle, Washington, USA PubMed articles Google scholar articles

Correspondence to Saul Eugene Rivkin; saul.rivkin{at}swedish.org

View Full Text

Citation

Rivkin SE, Moon J, Iriarte DS, et al

Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients

International Journal of Gynecologic Cancer Published Online First: 29 January 2019. doi: 10.1136/ijgc-2018-000035

Publication history

Received April 23, 2018
Revision received September 5, 2018
Accepted September 7, 2018
First published January 29, 2019.

Article Versions

View the most recent version of this article
You are currently viewing a Previous version of this article (31 March 2021).

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

other Versions

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

other Versions

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password